The pandemic—a manufactured event to create demand for the vaccine.
After examining corona virus patent applications since 1999, Dr. David E. Martin concludes that SARS-CoV-2 is neither novel, nor unexpected given the pharmaceutical industries’ 20-year desire to create a vaccine to treat it.
David E. Martin, PhD
Dr. David Martin is the founding CEO of M∙CAM Inc. M∙CAM is the international leader in intellectual property-based financial risk management. From auditing patent quality for governments and patent offices, to providing state-of-the-art actuarial risk management systems and solutions to the largest banks and insurance companies, M∙CAM has established a global standard in patent quality and commercial validity assessment and management.
A spokesperson for global intellectual property accountability and quality reform, Dr. Martin has worked closely with the United States Congress, numerous trade and finance regulatory agencies in the United States, Europe and Asia, in advocating and deploying infrastructure to support growing reliance on proprietary rights in business transactions. M∙CAM has supported the modernization of intellectual property, tax, and accounting laws through its work with oversight agencies and policy makers.
Dr. Martin has publications in law, medicine, engineering, finance and education. He maintains active research in the fields of linguistic genomics, fractal financial risk modeling, as well as continuing his over 15 years of research in cellular membrane ionic signaling.
Dr. Reiner Fuellmich
Dr. Reiner Fuellmich was born and raised in Bremen. He attended school in Bremen and Farmington Hills, Michigan. He studied law at the Georg-August University in Göttingen and in Los Angeles.
Among other things, he worked as a research assistant at the law faculty of the Georg-August University in Göttingen, where he did his doctorate. Before joining the law firm Dr. Fuellmich, he worked in the corporate banking of Deutsche Bank in Germany and Japan.
Dr. Fuellmich has published various articles and books in the fields of banking law, medical law and international private law and has taught as a professor and lecturer at universities in Germany and Estonia.
© 2023 FM Media Enterprises, Ltd.